A Study of Oraxol® in Gastric Cancer Patients

PHASE1/PHASE2UnknownINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

March 31, 2012

Study Completion Date

December 31, 2012

Conditions

Advanced Metastatic Gastric CancerRecurrent Gastric Cancer

Interventions

DRUG

Paclitaxel

HM30181AK 15 mg tablet + Paclitaxel 10mg, 30mg capsules

Trial Locations (2)

RECRUITING

National Cancer Center, Goyang

RECRUITING

Seoul National University Hospital, Seoul